On November 4, Axinn partner Chad Landmon will moderate the panel, "Biosimilars Action Plan Scorecard: Is FDA Helping Adoption?" at the GRx+Biosims Conference in North Bethesda, Maryland. Chad's panel will address the ways FDA policy is affecting both the US and global biosimilars markets.
Taking place November 4-6, this three-day event will feature top officials and subject matter experts who will share their knowledge on how to succeed in generic and biosimilar development, the regulatory process and approvals, and the evolving policy landscape.
Click here for more information, including how to register.